Inflation is slowly falling, while student debt is climbing: 6 graphs that explain today’s CPI 
Why is whooping cough surging in the UK? Falling vaccination rates may be answer 
Semaglutide's Benefits Beyond Weight Loss: New Insights from the SELECT Trial 
Coca-Cola Launches Lens Platform to Offer Key Data for Retail and Foodservice 
Aldi, Hy-Vee Recall Cream Cheese Products Over Potential Salmonella Contamination 
What’s the difference between ADD and ADHD? 
Some experts say the US economy is on the up, but here’s why voters don’t think so 
Supporting ‘democracy’ is hard for many who feel government and the economy are failing them 
If the RBA’s right, interest rates may not fall for another year. Here’s why. 
Why banks consider renewable energy to be a riskier investment than fossil fuels 
Rishi Sunak wants to cut the cost of ‘sicknote’ Britain 
Green industry yes, conservation no: a budget for people, not for nature 
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January.
The increases are in preparation for the Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices for some drugs starting in 2026.
The pharmaceutical industry is also dealing with inflation and supply chain constraints that increased manufacturing costs.
The price hikes are based on list prices, which do not account for other discounts or rebates to pharmacy benefit managers.
According to data released by 46brooklyn, a drug pricing non-profit affiliated with 3 Axis, drugmakers increased prices on more than 1,400 pharmaceuticals in 2022. Since 2015, there have been the most rises.
According to Antonio Ciaccia, president of 3 Axis, drugmakers have concentrated on releasing their medications at higher prices due to the concentration on annual price hikes.
More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.
Pfizer has so far disclosed the biggest price hikes, with 89 different prescription names seeing a rise in price in addition to an extra 10 drug brands at its Hospira division.
Then came GSK, which has already announced hikes for 26 different medications, including nearly a 7% rise for its well-known shingles vaccine Shingrix.
